The News Review:
- Dusa Reports Results From Phase IIb Acne Trial
- Dermatologists Say Teenagers Don’t Have To Suffer From Acne
- Isolagen completes injections of Isolagen Therapy in acne scar study
- Control imperfections
Dusa Reports Results From Phase IIb Acne Trial
RedOrbit, TX
The study has demonstrated that both treatments were safe and well tolerated with no serious adverse events. While both groups showed a statistically significant reduction in inflammatory lesions from baseline, the results did not demonstrate a statistically significant difference between the Levulan PDT and control groups. Based on these results, Dusa will not pursue further clinical development of Levulan PDT in combination with Blu-U for moderate to severe acne. Dusa remains committed to, and will focus its resources on continuing to grow the Levulan PDT franchise for the treatment of Grade 1-2 actinic keratoses (AKs) and pursuing other clinical development projects, such as the treatment of AKs and the prevention of squamous cell carcinomas in solid organ transplant recipients (SOTR). Dusa expects to begin enrollment in the SOTR study by the end of 2008. A service of YellowBrix, Inc. Source: Datamonitor More News in this Category.
Related: Bebida Beverage Phase One Testing Complete on Brazilian Water Source
Dermatologists Say Teenagers Don’t Have To Suffer From Acne
WDIV, MI
“It’s so embarrassing you just want to curl up in a ball. “Henry Ford dermatologist Dr. Linda Stein Gold said the majority of teenagers will develop acne at some point, and it doesn’t end there. “More than 80 percent of teenagers experience some form of acne,” said Stein Gold. “Even in adults, ages 20 to 30, about 80 percent of them will still have some form of acne. “Stein Gold said parents and doctors should take acne seriously.
Isolagen completes injections of Isolagen Therapy in acne scar study
Pharmaceutical Business Review
Isolagen anticipates the acne study will conclude in the first quarter of 2009. The Isolagen process is said to be an innovative cellular processing system which creates a natural, living cell therapy. By multiplying a patient’s own collagen-producing cells or fibroblasts into tens of millions of new cells, a personalized treatment is created which is then returned to the patient’s skin. This treatment, known as the Isolagen Therapy, is designed to improve skin damage caused by the normal effects of aging, sun damage, acne and burns. Declan Daly, CEO of Isolagen, said: “We are very excited that our acne program is progressing on time and we believe the dermatology community will be very interested in this data early next year because of the unmet need for a minimally invasive acne scar treatment.
Control imperfections
The Sun Daily, Malaysia
Consequently, women find it hard to define their skin, which is neither truly oily, dry, acne prone nor sensitive. They prefer to talk about skin which isn?t clean looking, which is “imperfect” skin ? skin with imperfections.